Skip to content

Improving Diabetes Care Collaboratively in the Community

Improving Diabetes Care Collaboratively in the Community

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00359996
Enrollment
6993
Registered
2006-08-03
Start date
2000-06-30
Completion date
2006-08-31
Last updated
2016-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

diabetes, quality improvement, community health center, health disparities

Brief summary

The purpose of this study is to determine whether a quality improvement intervention including rapid quality improvement, a chronic care model, and best practices improves diabetes care in community health centers and whether more intensive interventions enhance care further.

Detailed description

In 1998 the Health Resources and Services Administration's Bureau of Primary Health Care began the Health Disparities Collaborative (HDC) to improve chronic disease management in community health centers (HC) nationwide. The HDC incorporates rapid quality improvement (QI), a chronic care model, and best practices. This study determines if the HDC improves diabetes care and whether more intensive interventions with additional learning sessions for health centers, provider training in behavioral change, and patient empowerment materials enhance care further.

Interventions

BEHAVIORALhealth disparities collaborative

The HDC incorporates rapid quality improvement (QI), a chronic care model, and best practices. This study determines if the HDC improves diabetes care and whether more intensive interventions with additional learning sessions for health centers, provider training in behavioral change, and patient empowerment materials enhance care further.

OTHERNo additional educational sessions

Sponsors

Agency for Healthcare Research and Quality (AHRQ)
CollaboratorFED
Robert Wood Johnson Foundation
CollaboratorOTHER
University of Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

\- patients with diabetes age 18-75 years

Exclusion criteria

Pregnant women \-

Design outcomes

Primary

MeasureTime frameDescription
hemoglobin A1c4 yearsChange in hemoglobin A1c from baseline

Secondary

MeasureTime frameDescription
Lipid levels4 yearsChange in Lipid blood levels from baseline
Blood pressure4 yearsChange in BP from baseline
Urine microalbumin levels4 yearsChange in urine micralbumin levels from baseline

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026